Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Int Urogynecol J. 2012 Jun 29;24(1):91–97. doi: 10.1007/s00192-012-1848-2

Table 1.

Participant Characteristics (variables controlled for age)

Variable with PFDs
n=308(%)
without PFDs
n=197(%)
P-value

Age* 55.6 ±
10.8
51.6 ± 8.3 < 0.001

Race
African American 45(15%) 47(23%)
White 222(72%) 121(62%) NS
Other 10(3%) 8(4%)

BMI* 29.5 ± 8.0 27.9 ± 7.0 NS

Parity 2.6 2.1 0.003

Relationship status
Single 90(28%) 58(31%)
Married/Stable
relationship
217(72%) 138(69%) NS

Hormone Replacement
Therapy(HRT)
Menopausal (without
HRT)
41 40 NS
Menopausal (with oral or
vaginal HRT)
108 106

**Co-morbid medical
conditions
99 (47%) 113 (38%) NS

Depression 67 (21%) 28 (14%) NS

Surgical History
Hysterectomy 99(32%) 34(17%) 0.002
Bilateral salpingo-
oophorectomy
54(17%) 16(8%) 0.001

***Sexual activity rates Women
withPFDs
125(61%)
Women without
PFDs
208(71%)
0.44
*

Means ± standard deviations (SD)

**

Co-morbid conditions included Diabetes Mellitus, Hypertension, Coronary Artery Disease, stroke and multiple sclerosis

***

when controlled for age